drugset / Trial / NCT00190905

Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.

NCT00190905

Phase 4 Completed 4000 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the trial is to study the safety and effectiveness of duloxetine HCl in women of different backgrounds with stress urinary incontinence who may also have other various medical conditions.

Timeline

Start
2004-02
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule